Lithotripsy Device Market Report 2025

The lithotripsy device market size has grown strongly in recent years. It will grow from $1.83 billion in 2024 to $1.92 billion in 2025 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to risen incidence of kidney stones, preference for non-invasive procedures, advancements in medical imaging, increased geriatric population, patient demand for faster recovery.

The lithotripsy device market size is expected to see strong growth in the next few years. It will grow to $2.47 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to technological innovations in lithotripsy, increasing awareness and education, global access to healthcare services, collaborations in urology and nephrology, preventive approaches to kidney stones. Major trends in the forecast period include remote monitoring and telesurgery, continued research in stone fragmentation techniques, global collaboration in lithotripsy research, focus on outcomes-based healthcare, integration of artificial intelligence (ai).

The increasing prevalence of kidney stones is anticipated to drive the lithotripsy device market in the coming years. Kidney stones are solid, pebble-such as formations that can develop in one or both kidneys due to an excess of specific minerals in the urine. Lithotripsy devices play a crucial role in treating kidney stones by breaking them into smaller pieces using shockwaves, facilitating easier passage through urine. A study published by BioMed Central revealed that the Age-standardized prevalence rate (ASPR) of kidney stones was 21.11% in a population aged 40-70 years in Kharameh. The estimated ASPR was 24.13% in men and 18.7% in women in 2022, emphasizing the growing prevalence of urolithiasis and propelling the lithotripsy device market.

The increase in healthcare expenditures is expected to contribute to the growth of the lithotripsy device market. Healthcare expenditures encompass all costs related to providing health services, family planning, nutrition programs, and emergency assistance, playing a crucial role in enhancing accessibility and technological advancements in lithotripsy devices. In 2021, healthcare spending in the United States rose by 2.7% to $12,914 per person, totaling $4.3 trillion and accounting for 18.3% of the country's GDP. This substantial rise in healthcare expenditures is a driving force behind the growth of the lithotripsy device market.

A prominent trend in the lithotripsy device market is the emergence of product innovations. Major companies in the market are actively developing new and advanced products to strengthen their market position. In March 2022, Shockwave Medical Inc., a US-based medical device company, introduced the Shockwave M5+ peripheral IVL catheter following CE Mark and U.S. Food and Drug Administration (FDA) clearance. This innovative peripheral catheter is designed to reduce IVL treatment duration, broaden access options, and extend IVL therapy to individuals with larger vessel sizes, signifying a significant leap forward in lithotripsy device technology.

Major companies in the lithotripsy device market are prioritizing the development of advanced treatment facilities to expand patient access and improve treatment outcomes. These state-of-the-art facilities incorporate cutting-edge technologies and specialized care, offering comprehensive healthcare services. In May 2023, Government Kilpauk Medical College (KMC) Hospital in India inaugurated an extracorporeal shock wave lithotripsy (ESWL) treatment center, utilizing shock waves to non-invasively break kidney stones into small pieces for easier elimination through urine. The ESWL machine, valued at ₹2.3 crore, was generously sponsored by the MOBIS India Foundation as part of its corporate social responsibility funding.

In May 2024, Johnson & Johnson, a U.S.-based company specializing in medical devices, pharmaceuticals, and consumer health products, acquired Shockwave Medical for an undisclosed amount. This acquisition was intended to strengthen Johnson & Johnson's cardiovascular portfolio by incorporating Shockwave Medical's innovative solutions for treating calcified cardiovascular disease, with an emphasis on expanding minimally invasive treatment options. Shockwave Medical is known as a U.S. provider of lithotripsy devices.

Major companies operating in the lithotripsy device market include Boston Scientific Corporation,Cook Medical LLC,Shockwave Medical Inc.,Lumenis Ltd.,EDAP TMS S.A.,Dornier MedTech GmbH, Allengers Medical Systems Limited,DirexGroup,Medispec Ltd.,Elmed Medical Systems Ltd.,Convergent Laser Technologies,MTS Medical,NOVAmedtek LLC,EMD Medical Technologies,NIDHI Meditech Systems, Olympus Scientific Solutions Americas Corporation,Richard Wolf India Private Ltd.,Karl Storz SE & Co. KG,Technomed Systems Private Limited,Shenzhen Wikkon Medical Apparatus Co. Ltd.,Inceler Medikal Ltd. Sti,Cliniva Healthcare,C. R. Bard Inc.,E.M.S. Electro Medical Systems S.A.,MACHIDA Endoscope Co. Ltd.,Medtronic plc, Aymed Medical Technology Co. Ltd.,Proteus Digital Health Inc.

North America was the largest region in the lithotripsy devices market in 2024. The regions covered in the lithotripsy device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the lithotripsy device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Lithotripsy devices are medical instruments designed for the treatment of lithotripsy, a non-invasive procedure used to address kidney stones. This procedure employs shock waves or ultrasound waves to break large stones, which may be obstructing the urinary tract, into smaller, more manageable fragments.

The primary types of lithotripsy devices include extracorporeal shock wave lithotripsy devices and intracorporeal lithotripsy devices. Extracorporeal shock wave lithotripsy devices utilize shock waves generated by a lithotripter. These devices find applications in the treatment of kidney stones, ureteral stones, pancreatic stones, bile duct stones, and other related conditions, and are commonly used in hospitals, ambulatory surgical centers, and other medical facilities.

The lithotripsy device market research report is one of a series of new reports that provides lithotripsy device market statistics, including lithotripsy device industry global market size, regional shares, competitors with a lithotripsy device market share, detailed lithotripsy device market segments, market trends and opportunities, and any further data you may need to thrive in the lithotripsy device industry. This lithotripsy device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lithotripsy devices market consists of sales of laser lithotripsy, mechanical lithotripsy, and electrohydraulic lithotripsy. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.